| Date Filed | Type | Description |
| 05/18/2023 |
4
| Orion Sponsor Holdings, LLC (10% Owner) has filed a Form 4 on Orion Biotech Opportunities Corp.|
Txns:
| Disposed/sold 4,879,999 options to buy
@ $0 |
|
| 05/18/2023 |
4
| Collins James J. (Director) has filed a Form 4 on Orion Biotech Opportunities Corp.|
Txns:
| Disposed/sold 40,000 options to buy
@ $0 |
|
| 05/18/2023 |
4
| Broder Samuel (Director) has filed a Form 4 on Orion Biotech Opportunities Corp.|
Txns:
| Disposed/sold 40,000 options to buy
@ $0 |
|
| 05/18/2023 |
4
| Rodriguez Louisa (Director) has filed a Form 4 on Orion Biotech Opportunities Corp.|
Txns:
| Disposed/sold 40,000 options to buy
@ $0 |
|
| 05/11/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 05/01/2023 |
25
| Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities: |
| 04/24/2023 |
8-K
| Quarterly results |
| 03/29/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 08/12/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 05/10/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 03/24/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 02/15/2022 |
SC 13G
| Fir Tree Partners reports a 5% stake in Orion Biotech Opportunities Corp. |
| 02/14/2022 |
SC 13G
| Orion Sponsor Holdings, LLC reports a 31.5% stake in Orion Biotech Opportunities Corp. |
| 12/20/2021 |
10-Q/A
| Quarterly Report for the period ended September 30, 2021 [amend] |
| 12/20/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 12/20/2021 |
8-K
| Quarterly results |
| 11/12/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 10/15/2021 |
SC 13G
| GERALD D. HOSIER REVOCABLE TRUST reports a 7.5% stake in Orion Biotech Opportunities Corp. |
| 08/12/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 07/02/2021 |
8-K
| Quarterly results |
| 06/30/2021 |
4
| Orion Sponsor Holdings, LLC (10% Owner) has filed a Form 4 on Orion Biotech Opportunities Corp.|
Txns:
| Disposed of 750,000 options to buy
@ $0 |
|
| 06/29/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/28/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 05/21/2021 |
8-K
| Quarterly results |
| 05/21/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/18/2021 |
8-K
| Quarterly results |
| 05/14/2021 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 05/13/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/12/2021 |
3
| Broder Samuel (Director) has filed a Form 3 on Orion Biotech Opportunities Corp. |
| 05/12/2021 |
3
| Simonds Robert Kenneth (Director) has filed a Form 3 on Orion Biotech Opportunities Corp. |
| 05/12/2021 |
3
| Rodriguez Louisa (Director) has filed a Form 3 on Orion Biotech Opportunities Corp. |
| 05/12/2021 |
3
| Kayal Mark (CFO) has filed a Form 3 on Orion Biotech Opportunities Corp. |
| 05/12/2021 |
3
| Huang James (CEO) has filed a Form 3 on Orion Biotech Opportunities Corp. |
| 05/12/2021 |
3
| Collins James J. (Director) has filed a Form 3 on Orion Biotech Opportunities Corp. |
|